BlackBerry Limited (NYSE: BB) beat earnings estimates for the third quarter of 2020, sending the stock climbing 5.8% in premarket hours on Friday. The consensus estimate was for earnings of $0.02 per share on revenue of $275 million.
The company reported an 18% increase in GAAP revenue to $267 million during the quarter compared to the same period a year ago. Adjusted revenue increased 23% to $280 million.
On a GAAP basis, BlackBerry reported a net loss of $32 million compared to a net income of $59 million last year. GAAP loss per share was $0.07 compared to a loss of $0.01 per share last year. Adjusted EPS totaled $0.03.
Total GAAP software and services revenue increased 21% year-over-year to $262 million. On an adjusted basis, software and services revenue rose 26% to $275 million. Adjusted recurring software and services revenue (excluding IP licensing and professional services) was over 90%.
Also read: Accenture Q1 2020 Earnings Report
On a geographic basis, revenues increased in the North America and EMEA regions while in Other regions, it remained flat versus the prior-year quarter. By products and services, IoT revenues dipped slightly during the quarter versus last year while licensing revenues saw a double-digit increase. BlackBerry Cylance generated $40 million in revenues during the quarter.
Total cash, cash equivalents, short-term and long-term investments was $970 million as of November 30, 2019. Capital expenditures totaled $3 million in the third quarter.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company